Table 7.

The impact of alternative downstream operation sequences on the process cost and lipids price

Scenario	FCI ($)	CUT ($)	CRM ($)	COL ($)	COM ($)
Base scenario	16,085,855	3,880,618	4,614,114	450,000	14,572,474
No sterilisation	14,085,713	3,808,001	4,614,114	425,000	14,054,880
Thermotolerant strain	14,275,942	3,946,869	4,614,114	450,000	14.328,178
Zero-cost electricity	16,085,855	2,696,193	4,614,114	450,000	13,115,631
Wet extraction 1	29,818,363	1,398,219	4,615,182	325,000	13,651,038
Wet extraction 2	14,453,269	2,532,399	4,614,114	400,000	12,483,798
Use of whole cells	12,718,507	2,694,037	4,612,512	275,000	12,027,137
Continuous extracellular lipids	19,145,521	1,295,366	104,669	300,000	10,318,648